J. Wood Capital Advisors
Overview
J. Wood Capital Advisors is an advisory firm and registered broker-dealer focused solely on providing capital structure advice and solutions to U.S. corporations. The firm specializes in offering capital structure advice and solutions tailored for corporate clients seeking to raise capital. J. Wood Capital Advisors primarily serves clients in the pharmaceutical, biotechnology, and information technology sectors, providing expertise designed to address the unique financial needs of these industries.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Tisento Therapeutics | Jul 2023 | Series A | Lead |
| Mighty Therapeutics | Nov 2022 | Take Private | Lead |
| KymaThera | Oct 2026 | Series B | Co-investor |
Key People
Katy Neumer
Managing Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is J. Wood Capital Advisors based?
J. Wood Capital Advisors is headquartered in Santa Rosa, California, United States.
When was J. Wood Capital Advisors founded?
J. Wood Capital Advisors was founded in 2013.
How many portfolio companies does J. Wood Capital Advisors have?
J. Wood Capital Advisors has 3 portfolio companies in Caplight's dataset.
What are some companies in J. Wood Capital Advisors's portfolio?
Portfolio companies visible on Caplight include Tisento Therapeutics, Mighty Therapeutics, KymaThera.
What was J. Wood Capital Advisors's most recent investment shown here?
J. Wood Capital Advisors's most recent investment in this portfolio sample was in KymaThera in 2026.
What sectors does J. Wood Capital Advisors focus on?
J. Wood Capital Advisors focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does J. Wood Capital Advisors focus on?
Stage focus information for J. Wood Capital Advisors is not publicly available.